marcus evans europe conferences

3rd Annual Portfolio Management Strategies for Biosimilars & Generics

Acknowledge New Trends in Profitable Markets —Value-added/Complex generics & Biosimilars—, Seek for Strategic Alliances to Improve Marketing and Commercial Strategies, Understand Stakeholder's Opinions to Success in different Markets

13-15 February 2019
Barcelona, Spain

Conference Workshop

Explore Digital Tools and Market Access Strategies

Different countries’ dynamics and regulations transform market access into a hard task to complete. This workshop will help participants to employ tools and develop strategies to overcome these constraints. Additionally, it will discuss the possibility to develop products that meet the criteria for different regions.

Workshop Moderator: Erez Hybloom, Former Senior Director, Global Portfolio and Europe Portfolio

Company: Teva (formerly)


Why You Should Attend

3rd Annual Portfolio Management Strategies for Biosimilars & Generics

marcus evans’ upcoming 3d annual conference in Portfolio Management Strategies for Biosimilars and Generics bestows a place for pharmaceutical companies to share outlooks, concerns and impressions in a professional environment. We want to give you the means to apply new strategies to enter multiple markets with different regulations, strengthen commercial and marketing relationships, build strategic alliances, understand stakeholder's opinions and consider value-added generics and biosimilars markets to find less overcrowded and more profitable markets. This annual event will also provide you with a great chance to not only benchmark with big Pharma companies but with successful small/mid-size ones that are thriving in an extremely competitive market. We wish not only to create a professional environment but a distended atmosphere where attendees are able to schedule one-to-one meetings with our exceptional speakers and meet peers who are willing to discuss their strategies and approaches in highly interactive roundtables, panel discussions and workshops.”

“The latest updates show that not many blockbuster drug's patents are about to expire and only a few companies in the top 20 generics market had a positive growth in the last year. The generics' market faces a stagnant future landscape. In this grey scenery, it is high time that pharmaceutical companies look after their portfolio.


Key Topics

  • Sandoz designing a combined portfolio of biosimilars and generics
  • Biocon evaluating the power of strategic alliances
  • Accord Healthcare bringing together portfolio and project management
  • CSA Healthcare evaluating the criteria for driving high valuable portfolios
  • Gedeon Ritcher discussing the best marketing practices
  • Previous Attendees Include

    • ABBOTT LABORATORIES
    • ABBVIE
    • ASTELLAS
    • ACTELION
    • ASTRAZENECA
    • ALMIRALL
    • AMGEN
    • ASTELLAS
    • BAXALTA
    • BAXTER
    • BAYER
    • BIOGEN IDEC
    • BRISTOL-MYERS SQUIBB
    • BOEHRINGER INGELHEIM
    • CELGENE
    • CHIESI FARMACEUTICI SPA
    • ELI LILLY
    • GLAXOSMITHKLINE
    • IPSEN
    • JANSSEN PHARMACEUTICAL
    • JOHNSON & JOHNSON
    • MERCK
    • MITSUBISHI TANABE PHARMACEUTICALS
    • NOVARTIS
    • ORION CORPORATION
    • PFIZER
    • SANOFI-AVENTIS
    • SHIRE INTERNATIONAL
    • TAKEDA
    • TEVA PHARMACEUTICALS


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.






    Practical Insights From

    Kirsi Norvasuo-Huber
    Head Strategic Portfolio Management
    Sandoz

    Detlef Behrens
    Head of CMO
    Biocon

    Catarina Lopes Pereira
    Market Access Manager
    Medicines for Europe

    Erez Hybloom
    Former Senior Director, Global Portfolio and Europe Portfolio
    Teva

    J. Ignacio Díaz
    Director of Business Development
    Qilu

    Amit Bansal
    Head Global Generics
    Sanofi

    Sameer Agarwal
    CEO
    CSA Healthcare

    Anna Aillerie
    Head of Commercial Operations
    Gedeon Richter

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference is well organised and speakers are all high quality!” - Programme Coordinator, J&J
    • “High quality speakers, enjoyed the networking” - VP, Debiopharm
    • “I appreciated the conference a lot, having the possibility to compare project management actions of my company with the other companies” - Project Manager R&D, Chiesi
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall


    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    Telephone:
    +357 22849 380
    Fax: +357 22849 394
    Email: constandinosv@marcusevanscy.com